|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07H 19/067 | (2006.01) |
| C07H 19/073 | (2006.01) | ||
| C07H 19/10 | (2006.01) | ||
| C07H 19/167 | (2006.01) | ||
| C07H 19/173 | (2006.01) | ||
| C07H 19/20 | (2006.01) | ||
| C07H 19/213 | (2006.01) | ||
| A61K 31/708 | (2006.01) | ||
| A61K 31/7076 | (2006.01) | ||
| A61K 31/7072 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2935303 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13864403.4 |
| Date of filing the European patent application | 2013-12-19 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (86) | Number | PCT/US2013/076740 |
| Date | 2013-12-19 |
| (87) | Number | WO 2014/100505 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 201261745466 P | 2012-12-21 | US | |
| 201361890125 P | 2013-10-11 | US |
| (72) |
BEIGELMAN, Leonid, US
WANG, Guangyi, US
SMITH, David, Bernard, US
|
| (73) |
Janssen BioPharma, Inc.,
260 E. Grand Avenue, 2nd Floor, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 4'-Fluor-nukleozidai, 4'-fluor-nukleotidai ir jų analogai, skirti HCV gydymui |
| 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV |
| Payment date | Validity (years) | Amount | |
| 2025-11-18 | 13 | 289.00 EUR |
| 2026-12-19 |